Efficacy and safety of switching to travoprost/timolol fixed-combination therapy from latanoprost monotherapy
Japanese Journal of Ophthalmology, 05/17/2012
Kashiwagi K – Compared to latanoprost monotherapy, travoprost/timolol fixed–combination therapy significantly reduced intraocular pressure and decreased the heart rate in the patient cohort. No differences were found in terms of patients’ impressions.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.